Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Merck aims to quickly repay up to $5 billion in loans - CFO in Boersen-Zeitung

Published 18/04/2015, 16:22
© Reuters. Branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt
MRCG
-
SIAL
-

FRANKFURT (Reuters) - Germany's Merck (DE:MRCG) aims to quickly repay the up to $5 billion (£3.3 billion) in bank loans it needed to fund the $17 billion acquisition of U.S. lab supplies company Sigma-Aldrich (O:SIAL), its finance chief told daily Boersen-Zeitung.

"We want to reduce the loans very aggressively within two to three years to stabilise our credit rating and to regain financial leeway for further acquisitions," Marcus Kuhnert told the paper in an interview published on Saturday.

The German drugs and chemicals maker is funding the biggest takeover in its history from about $2 billion to $3 billion in cash and the issue of new debt securities. It plans to close the deal in the middle of this year.

Kuhnert said that after the deal, net debt would be more than three times its earnings before interest, depreciation and amortisation (EBITDA) at 12 billion euros ($13 billion) and that Merck wanted to improve the ratio as soon as possible.

© Reuters. Branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt

He said he wanted the ratio lower than two times EBITDA by the end of 2017. "Then we can talk about smaller and mid-sized acquisitions again," Kuhnert said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.